Hello Friends! Are you looking to invest in the stock market, or have you already invested? Would you like to know the predictions regarding the potential fluctuations in your shares? If so, you have landed on exactly the right page. On this page, you will find information regarding Trualt bioenergy share price future, Trualt Bioenergy IPO share price, Trualt bioenergy share price history, TruAlt Bioenergy share price screener, TruAlt Bioenergy share price live, TruAlt Bioenergy Share price target 2030, and much more. Furthermore, this page provides details on TruAlt Bioenergy‘s share price targets 2026, 2027, 2028, 2029, 2030, 2040, and beyond.
TruAlt Bioenergy Company Information
| Founded |
2021 |
| Headquarters | India |
| Number of employees | 470 (2025) |
TruAlt Bioenergy Share Price Target Overview
- Current Price – 494.50
- Open – 480.85
- High – 498.30
- Low – 479.30
- Mkt cap – 4.24KCr
- P/E ratio – 42.04
- 52-wk high – 549.00
- 52-wk low – 310.20
- Dividend – N/A
- Qtrly div amt – N/A
TruAlt Bioenergy Share Price Chart
TruAlt Bioenergy Share Price Target Tomorrow (Prediction)
| TruAlt Bioenergy Share Price Target Years | TruAlt Bioenergy Share Price Target |
| 2026 | ₹560 |
| 2027 | ₹600 |
| 2028 | ₹650 |
| 2029 | ₹600 |
| 2030 | ₹750 |
TruAlt Bioenergy Share Price Target 2026
The target for TruAlt Bioenergy’s share price in 2026 is projected to range between ₹550 and ₹560. As of the end of May 2026, TruAlt Bioenergy’s share price stood at ₹494.50. Compared to the previous year, TruAlt Bioenergy’s share price has witnessed an decrease this year.
TruAlt Bioenergy Share Price Target 2027
The target for TruAlt Bioenergy’s share price in 2027 is projected to range between ₹590 and ₹600. On 22 May 2026, TruAlt Bioenergy Share price NSE is 494.50 INR. Compared to last year, no significant difference has been observed in the share price of TruAlt Bioenergy. The share price has decreased by approximately 40-50 rupees.
TruAlt Bioenergy Share Price Target 2030
The target for TruAlt Bioenergy’s share price in 2030 is projected to range between ₹740 and ₹750. Over the past several years, the company has generated substantial profits, and investors, too, have earned handsome returns proportionate to their shareholdings. We remain optimistic that the company will continue to generate profits in the future, thereby ensuring continued returns for its investors.
Read Also:- Unicommerce eSolutions Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
TruAlt Bioenergy Shareholding Pattern
| Promoter | 70.6% |
| FII | 0.7% |
| DII | 9.4% |
| Retails & Others | 19.4% |
| Mutual Funds | 0% |
Income Statement Of TruAlt Bioenergy
|
All values in INR
|
Mar 2025
|
Jun 2025
|
Sep 2025
|
Dec 2025
|
|---|---|---|---|---|
|
Revenue
|
4.15B
|
3.04B
|
1.15B
|
7.13B
|
|
Cost of goods sold
|
2.06B
|
2.20B
|
922.10M
|
4.94B
|
|
Cost of revenue
|
2.06B
|
2.20B
|
922.10M
|
4.94B
|
|
Research and development expenses
|
–
|
–
|
–
|
–
|
|
Total research and development expenses
|
–
|
–
|
–
|
–
|
|
Selling, general, and admin expenses
|
102.24M
|
111.97M
|
106.56M
|
124.60M
|
|
Operating expense
|
1.02B
|
632.96M
|
479.80M
|
1.07B
|
|
Total operating expenses
|
3.08B
|
2.83B
|
1.40B
|
6.01B
|
|
Operating income
|
1.07B
|
208.47M
|
-253.33M
|
1.12B
|
|
Other non operating income
|
154.26M
|
227.42M
|
147.57M
|
176.22M
|
|
EBT including unusual items
|
863.91M
|
58.00M
|
-491.75M
|
896.83M
|
|
EBT excluding unusual items
|
863.91M
|
58.00M
|
-491.75M
|
896.83M
|
|
Income tax expense
|
111.99M
|
10.74M
|
-112.35M
|
204.93M
|
|
Effective tax rate
|
12.96%
|
18.52%
|
22.85%
|
22.85%
|
|
Other operating expenses
|
739.22M
|
314.08M
|
165.41M
|
730.22M
|
|
Net income
|
751.92M
|
47.25M
|
-379.40M
|
693.32M
|
|
Net profit margin
|
18.11%
|
1.55%
|
-33.03%
|
9.72%
|
|
Earnings per share
|
–
|
–
|
–
|
–
|
|
Interest and investment income
|
–
|
–
|
–
|
–
|
|
Interest expense
|
-359.71M
|
-377.89M
|
-385.99M
|
-401.34M
|
|
Net interest expenses
|
-359.71M
|
-377.89M
|
-385.99M
|
-401.34M
|
|
Depreciation and amortization charges
|
176.64M
|
206.90M
|
207.84M
|
218.07M
|
|
EBITDA
|
1.25B
|
372.68M
|
-45.96M
|
1.29B
|
|
Gain or loss from assets sale
|
–
|
–
|
–
|
–
|
Read Also:- Anlon Healthcare Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Hi, I’m Ronak, a news writer covering the latest updates in automobiles, education, smartphones, and trending topics. I focus on delivering simple, clear, and timely news to keep readers informed about what’s happening around the world.